U.S. Blood Pressure Monitoring Devices Market (By Product: Digital Blood Pressure Monitor, Sphygmomanometer, Ambulatory Blood Pressure Monitor, Instruments & Accessories, Transducers; By End User: Ambulatory Surgical Centers & Clinics, Hospitals, Home Healthcare) - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on U.S. Blood Pressure Monitoring Devices Market 

5.1. COVID-19 Landscape: U.S. Blood Pressure Monitoring Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8.U.S. Blood Pressure Monitoring Devices Market, By Product

8.1. U.S. Blood Pressure Monitoring Devices Market Revenue and Volume, by Product, 2024-2033

8.1.1. Digital Blood Pressure Monitor

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Sphygmomanometer

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

8.1.3. Ambulatory Blood Pressure Monitor

8.1.3.1. Market Revenue and Volume Forecast (2021-2033)

8.1.4. Instruments & Accessories

8.1.4.1. Market Revenue and Volume Forecast (2021-2033)

8.1.5. Transducers

8.1.5.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. U.S. Blood Pressure Monitoring Devices Market, By End User

9.1. U.S. Blood Pressure Monitoring Devices Market Revenue and Volume, by End User, 2024-2033

9.1.1. Ambulatory Surgical Centers & Clinics

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Hospitals

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

9.1.3. Home Healthcare

9.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. U.S. Blood Pressure Monitoring Devices Market and Trend Forecast

10.1. U.S.

10.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)

10.1.2. Market Revenue and Volume Forecast, by End User (2021-2033)

Chapter 11. Company Profiles

11.1. Koninklijke Philips N.V.

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. General Electric Company

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. SunTech Medical, Inc.

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Welch Allyn

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. American Diagnostic Corporation

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Briggs Healthcare

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Spacelabs Healthcare

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. GF HEALTH PRODUCTS, INC.

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Rossmax International Limited

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Microlife Corporation

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

PROCEED TO BUY :

   USD 5400
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample